ArticleBMJ open2022

Rationale and design of a prospective study evaluating population pharmacokinetics and pharmacodynamics of rivaroxaban in Chinese patients with non-valvular atrial fibrillation.

Xiao-Qin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.